v3.19.3
Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
$ in Thousands
Total
Exchange Under 3(a)(9) [Member]
Exchange Under 4(a)(2) [Member]
Preferred Stock [Member]
Common Stock [Member]
Common Stock [Member]
Exchange Under 3(a)(9) [Member]
Common Stock [Member]
Exchange Under 4(a)(2) [Member]
Additional Paid-In Capital [Member]
Additional Paid-In Capital [Member]
Exchange Under 3(a)(9) [Member]
Additional Paid-In Capital [Member]
Exchange Under 4(a)(2) [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2017 $ (2,336)       $ 1     $ 7,578     $ (129) $ (9,786)
Beginning Balance, shares at Dec. 31, 2017       4,408,000 5,781,000              
Exchange of shares in connection with reverse merger 6,183       $ 2     6,181        
Exchange of shares in connection with reverse merger, shares       (3,644,000) (3,994,000)              
Sale of common and preferred stock 1,750             1,750        
Sale of common and preferred stock, shares         175,000              
Foreign currency translation (132)                   (132)  
Net loss (2,766)                     (2,766)
Ending Balance at Mar. 31, 2018 2,699       $ 3     15,509     (261) (12,552)
Ending Balance, shares at Mar. 31, 2018       764,000 1,962,000              
Beginning Balance at Dec. 31, 2017 $ (2,336)       $ 1     7,578     (129) (9,786)
Beginning Balance, shares at Dec. 31, 2017       4,408,000 5,781,000              
Equity grant, shares 0                      
Net loss $ (9,441)                      
Ending Balance at Sep. 30, 2018 13,609       $ 8     33,808     (980) (19,227)
Ending Balance, shares at Sep. 30, 2018       438,000 7,678,000              
Beginning Balance at Mar. 31, 2018 2,699       $ 3     15,509     (261) (12,552)
Beginning Balance, shares at Mar. 31, 2018       764,000 1,962,000              
Stock-based compensation 200             200        
Stock-based compensation, shares         42,000              
Sale of common and preferred stock 3,585     $ 1       3,584        
Sale of common and preferred stock, shares       298,000 885,000              
Conversion of preferred stock to common stock, shares       (404,000) 404,000              
Foreign currency translation (656)                   (656)  
Net loss (2,944)                     (2,944)
Ending Balance at Jun. 30, 2018 2,884     $ 1 $ 3     19,293     (917) (15,496)
Ending Balance, shares at Jun. 30, 2018       658,000 3,293,000              
Debt exchange   $ 11,445 $ 1,024     $ 3 $ 1   $ 11,442 $ 1,023    
Debt exchange, shares           3,110,000 290,000          
Unitron option exercise 1,791       $ 1     1,790        
Unitron option exercise, shares         625,000              
Conversion of preferred stock to common stock (1)     $ (1)                
Conversion of preferred stock to common stock, shares       (220,000) 220,000              
Exercise of common stock warrants, shares         81,000              
Equity grant $ 260             260        
Equity grant, shares 0       59,000              
Foreign currency translation $ (63)                   (63)  
Net loss (3,731)                     (3,731)
Ending Balance at Sep. 30, 2018 13,609       $ 8     33,808     (980) (19,227)
Ending Balance, shares at Sep. 30, 2018       438,000 7,678,000              
Beginning Balance at Dec. 31, 2018 (2,757)       $ 8     35,303     (1,011) (37,057)
Beginning Balance, shares at Dec. 31, 2018       322,000 7,793,000              
Debt exchange 173             173        
Debt exchange, shares         93,000              
Exercise of common stock warrants 1,154             1,154        
Exercise of common stock warrants, shares         382,000              
Foreign currency translation (35)                   (35)  
Net loss (3,659)                     (3,659)
Ending Balance at Mar. 31, 2019 (5,124)       $ 8     36,630     (1,046) (40,716)
Ending Balance, shares at Mar. 31, 2019       322,000 8,268,000              
Beginning Balance at Dec. 31, 2018 $ (2,757)       $ 8     35,303     (1,011) (37,057)
Beginning Balance, shares at Dec. 31, 2018       322,000 7,793,000              
Equity grant, shares 0                      
Net loss $ (12,597)                      
Ending Balance at Sep. 30, 2019 (11,503)       $ 9     39,153     (1,011) (49,654)
Ending Balance, shares at Sep. 30, 2019       25,000 9,246,000              
Beginning Balance at Mar. 31, 2019 (5,124)       $ 8     36,630     (1,046) (40,716)
Beginning Balance, shares at Mar. 31, 2019       322,000 8,268,000              
Stock-based compensation 1,750       $ 1     1,749        
Stock-based compensation, shares         681,000              
Issuance of warrants and beneficial conversion feature with convertible debt 750             750        
Foreign currency translation 1                   1  
Net loss (5,614)                     (5,614)
Ending Balance at Jun. 30, 2019 (8,237)       $ 9     39,129     (1,045) (46,330)
Ending Balance, shares at Jun. 30, 2019       322,000 8,949,000              
Stock-based compensation $ 24             24        
Conversion of preferred stock to common stock, shares       (297,000) 297,000              
Equity grant, shares 0                      
Foreign currency translation $ 34                   34  
Net loss (3,324)                     (3,324)
Ending Balance at Sep. 30, 2019 $ (11,503)       $ 9     $ 39,153     $ (1,011) $ (49,654)
Ending Balance, shares at Sep. 30, 2019       25,000 9,246,000